Screener
Arcutis Biotherapeutics, Inc. ARQT Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
| Interest expense | (3,406) | (3,029) | (7,774) | (6,011) |
| Other income (expense), net | (157) | 20 | (177) | 213 |
| Total other income (expense) | (1,284) | (933) | (3,397) | (1,185) |
| Income (loss) before income taxes | 15,145 | (15,544) | 3,943 | (40,325) |
| Provision for income taxes | 136 | 342 | 229 | 621 |
| Net income (loss) | $15,009 | $(15,886) | $3,714 | $(40,946) |
| Other comprehensive income (loss): |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s other income (expense)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported other income (expense) of -$1.28M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s other income (expense) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s other income (expense) decreased by 37.6% year-over-year, from -$933K to -$1.28M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Arcutis Biotherapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude